SANTA MONICA, Calif. and HOUSTON, July 9, 2019 /PRNewswire/ -- symplr, a leading healthcare governance, risk and compliance ("GRC") software-as-a-service ("SaaS") platform, backed by Clearlake Capital Group, L.P. (together with its affiliates, "Clearlake") and SkyKnight Capital (together with its affi

MINNEAPOLIS, July 9, 2019 /PRNewswire/ -- In an effort to keep active, wellness-minded individuals at their peak performance levels – from the boardroom to the gym – pioneering recreational oxygen company,

MADISON, Wis., July 9, 2019 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced that the company will host webcasts and conference calls of its annual stockholders meeting and its second-quarter 2019 financial results.

SOUTH SAN FRANCISCO, Calif., July 9, 2019 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics to treat cancer, announced the promotions of Paul A. Stone, J.D., as Chief Financial Officer, Andres

FRISCO, Texas, July 9, 2019 /PRNewswire/ -- Argon Medical Devices, Inc., a leading global manufacturer of specialty medical devices used in interventional procedures, announced today that it has entered into a definitive license agreement with Hatch Medical, L.L.C. ("Hatch Medical") for exclusive global rights to market and distribute the Scorpion™ TIPS Access

LOS ANGELES, July 9, 2019 /PRNewswire/ -- ImaginAb Inc., a clinical stage immuno-oncology imaging company, announced today that it has entered into a non-exclusive license and collaboration agreement with Roche. Under the terms of the agreement, Roche will use ImaginAb's novel minibody CD8 T cell imaging agent in immuno-oncology clinical trials for multiple types of

CLEVELAND, July 9, 2019 /PRNewswire/ -- Vanderbilt-Ingram Cancer Center and GenomOncology LLC announce the launch of the newly redesigned and improved My Cancer Genome website. The new site showcases the breadth and depth of curated content from My Cancer Genome.

MUMBAI, India, July 9, 2019 /PRNewswire/ -- India-based Accutest Biologics Private Limited (ABPL), a leading CRO for high-quality Biochemical characterization and Bioanalytical services supporting preclinical and clinical development of Biologics and Biosimilars, has received the prestigious OECD-Good Laboratory Practice (GLP) certificati

STOCKHOLM, July 9, 2019 /PRNewswire/ -- Clinical study data on switching haemophilia A and B patients from on-demand treatment to extended half-life (EHL) prophylaxis showed a positive impact on clinical outcomes, with improvements in quality of life (QoL) and reduced annual bleeding rates (ABR). The results of these joint studies by

RIDGEFIELD, Conn., July 8, 2019 /PRNewswire/ -- Boehringer Ingelheim today announced results from two pediatric studies of Pradaxa®, which were presented at the International Society on Thrombosis and Haemostasis (ISTH) 2019 Congress in Melbourne, Australia.